2. UroToday Home
  3. Conference Highlights
  4. SIU Congress 2017

SIU 2017 Kidney Cancer

SIU 2017: UP21 - Usefulness of Laparoscopic Partial Adrenalectomy: Single Surgeon Experience

Lisbon, Portugal (UroToday.com) There is growing interest in partial adrenalectomy to avoid the side effects of potential adrenal insufficiency and life-long steroid replacement in select cases. Therefore, the authors presented a study evaluating the usefulness of laparoscopic partial adrenalectomy (LPA) by comparing the surgical and long-term functional results of LPA to those of laparoscopic total adrenalectomy (LTA).

 SIU 2017: UP17 - Carcinoma of the Collecting Ducts of Bellini - Clinicopathological Features

Lisbon, Portugal (UroToday.com) Carcinoma of the collecting ducts of Bellini (CDC) is a rare disease, thought to be derived from the cells of the collecting duct of Bellini and accounts for <1% of renal malignancies. The rarity of these tumours and heterogeneity of histopathologic features, which occasionally overlap with papillary renal cell carcinoma, and urothelial carcinoma of the kidney, limit our understanding of it. Optimal management of CDC is lacking. The authors therefore aimed to investigate the clinicopathologic features of CDC.

SIU 2017: UP15 - Current Diagnostic Accuracy of Conventional Computed Tomography Scan in Surgically Removed Benign Renal Tumors

Lisbon, Portugal (UroToday.com) There is a growing need to improve the accuracy of diagnosing benign renal tumors preoperatively, as it would reduce subsequent unnecessary invasive treatments. In this study, the authors evaluated the current accuracy of computed tomography (CT) for diagnosing benign renal tumors.

SIU 2017: Rationalising Follow Up for Bosniak IIF Cysts: A Multicentre Study

Lisbon, Portugal (UroToday.com) In this study, the authors build upon work they had previously published in 2016. In that study, they demonstrated that in a cohort of 198 patients with Bosniak IIF cysts, only 0.5% progressed into malignant lesions; if they progressed, it was within the first two years of follow-up. They had then recommended that patients with Bosniak IIF cysts could be discharged from follow-up after 2 stable years. In this study, they replicate similar findings in a separate institution.

SIU 2017: Is Laparoscopic Adrenalectomy by Lateral Retroperitoneal Approach Safe and Feasible Treatment Option for Pheochromocytoma Larger than 6cm?

Lisbon, Portugal (UroToday.com) Laparoscopic adrenalectomy for pheochromocytoma is a technically challenging procedure, traditionally approached by a transperitoneal approach. However, as with renal surgery, the retroperitoneal approach offers some benefits, particularly in obese patients. In this study, the group from South Korea examine the feasibility of laparoscopic adrenalectomy via a retroperitoneal approach (LRA) for large pheochromocytomas (PCC). 

SIU 2017: Is Laparoscopic Adrenalectomy by Lateral Retroperitoneal Approach Safe and Feasible Treatment Option for Pheochromocytoma Larger than 6cm?

Lisbon, Portugal (UroToday.com) Laparoscopic adrenalectomy for pheochromocytoma is a technically challenging procedure, traditionally approached by a transperitoneal approach. However, as with renal surgery, the retroperitoneal approach offers some benefits, particularly in obese patients. In this study, the group from South Korea examine the feasibility of laparoscopic adrenalectomy via a retroperitoneal approach (LRA) for large pheochromocytomas (PCC). 

SIU 2017: Growth Kinetics of Small Renal Mass: Initial Analysis of Korean Active Surveillance Registry

Lisbon, Portugal (UroToday.com) While active surveillance for small solid renal masses has been slowly gaining acceptance, different populations continue to assess the feasibility and safety of the management in their own unique populations. In this manuscript, the authors assess safety and natural history of AS of SRMs in their institute in Korea.
Page 1 of 6
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe